Sarah Hilkert Rodriguez

overview

Sarah Rodriguez, MD, MPH, provides comprehensive, compassionate care to children with decreased vision in one or both eyes. Dr. Rodriguez has a special interest in treating conditions caused by abnormal eye development, such as amblyopia (lazy eye), strabismus (misalignment of the eyes), pediatric cataracts, and retinopathy of prematurity. She also specializes in adjustable sutures for adult strabismus surgery.

Dr. Rodriguez is not only passionate about delivering high-quality care to her patients, but she is also dedicated to resident education and clinical research. Most of her research focuses on retinopathy of prematurity (ROP), and she recently received a grant from the Knights Templar Eye Foundation to study neurodevelopmental outcomes among infants screened for ROP. She is also the principle investigator for the University of Chicago's involvement in PEDIG. Dr. Rodriguez's research has been published in a number of scientific journals, including Ophthalmology, JAAPOS, and Pediatrics.

Having completed several medical mission trips to Ghana and Nicaragua, she also has an interest in health disparities and global health. She recently participated in ROP workshops in Vietnam and South Africa, and she is a committee member for IPOSC ROP Africa.

keywords

education and training

Northwestern Memorial / Lurie Children's Hospital, Chicago, IL	Fellowship	06/2016	Pediatric Ophthalmology
The Ohio State University Havener Eye Institute, Columbus, OH	Residency	06/2015	Ophthalmology
Scripps Mercy Hospital, San Diego, CA	Internship	06/2012	Transitional Year
The Ohio State University College of Medicine, Columbus, OH	MD	06/2011	Medicine
La Cayetana Hereredia, Lima, Peru		04/2011	Tropical Medicine Course
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD	MPH	05/2010	Public Health
University of Notre Dame, Notre Dame, IN	BA	06/2006	Phiosophy

awards and honors

2018 - 2019	Reviewer, Retina
2017 - 2019	Reviewer, JAAOPS
2014	Havener Eye Institute Free Clinic Certificate of Appreciation, Ohio State Havener Eye Institute
2014	Travel Grant Award for ARVO, National Eye Institute
2013	Consultant of the Month, Ohio State Havener Eye Institute
2012	Mercy Style of Care Award, Scripps Mercy Hospital
2011	Eli G. Alcon Award for Outstanding Senior Medical Student in Ophthalmology, The Ohio State University College of Medicine
2010	Capstone Award for Outstanding Achievement , Johns Hopkins Bloomberg School of Public Health
2010	Health Economics Certificate, Johns Hopkins Bloomberg School of Public Health
2010	AOA, The Ohio State University, College of Medicine
2009	Gold Humanism and Honor Society, The Ohio State University, College of Medicine

Twitter

Websites

research activities and funding

(Hilkert Rodriguez, Sarah)Jan 1, 2016 - Jun 30, 2017 Novartis Rainbow Study Role Description: a randomized, controlled study evaluating the efficacy and safety of ranibizumab compared with laser therapy for the treatment of infants born prematurely with retinopathy of prematurity. Role: PI

(Zhang, Michael)May 1, 2017 - Jun 30, 2017 Diversity Grant: Assessing Socioeconomic Status as a Risk Factor for Severe Retinopathy of Prematurity Role: Mentor for medical student, Michael Zhang

(Anand, Nandita)Jun 1, 2017 - Jun 1, 2018 Role Description: ISPB Research Grant: To evaluate the long term safety and efficacy of antivascular endothelial growth factor (anti-VEGF) treatment compared to laser among patients who received treatment for retinopathy of prematurity. Role: Mentor of ophthalmology resident

(Hilkert Rodriguez, Sarah)Aug 1, 2017 - Aug 1, 2018 Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity. Role: PI

(Hilkert Rodriguez, Sarah)Jan 1, 2018 Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity Role: PI

(Theophanous, Christos)Jun 1, 2018 ISPB Research Grant: Proteomics in pediatric cataracts. Role: Mentor for ophthalmology resident, Christos Theophanous

(Hilkert-Rodriguez, Sarah)Jun 1, 2018 - Jun 1, 2019 Knights Templar Evaluating the efficacy of a smartphone application (Baby Moves!) to detect developmental delays among a high risk population of infants screened for retinopathy of prematurity. Role: PI

(Hilkert-Rodriguez, Sarah)Oct 1, 2018 ROP Hot Topics Role Description: Co-organizer for international ROP meeting, raised funding from sponsors for meeting support Role: Co-organizer

(Elise Timtim)Jun 1, 2019 - Jun 30, 2020 ISBP ROP Outcomes using the Medicaid Claims Database Role: Mentor for medical student, Elise Timtim

(Elise Timtim)Jun 1, 2019 - Jun 30, 2020 AOA Carolyn L. Kuckein Student Research Fellowship ROP Outcomes using the Medicaid Claims Database Role: Mentor for medical student, Elise Timtim

(Hilkert Rodriguez, Sarah)Jun 25, 2019 PEDIG Role: PI for the University of Chicago

(Lindsay Chun)Jul 1, 2020 - Jun 30, 2021 ISPB Research Grant Evaluating endophthalmitis after pediatric cataract surgery using an insurance claims database Role: Mentor for Ophthalmology Resident

(Ema Avdagic)Jul 1, 2020 - Jun 30, 2021 ISPB Research Grant Systemic hypertension after intravitreal bevacizumab therapy for type 1 ROP: is there evidence for concern? Role: Mentor for Ophthalmology Resident

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

List All | Timeline

Blair MP, Rodriguez SH, Shapiro MJ. A potential solution to plus disease variability. Ophthalmology Retina. 2020; 4(10):1022-1023.

View Publication
Zhang MH, Blair MP, Ham SA, Rodriguez SH. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 Sep 01; 51(9):486-493. PMID: 32955587.

View in: PubMed
Skondra D, Rodriguez SH, Sharma A, Gilbert J, Andrews B, Claud EC. The early gut microbiome could protect against severe retinopathy of prematurity. J AAPOS. 2020 Jul 21. PMID: 32707176.

View in: PubMed
Rodriguez SH, Schechet SA, Shapiro MJ, Blair MP. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 Jun; 24(3):149.e1-149.e5. PMID: 32461148.

View in: PubMed
Rodriguez SH, Blair MP, Shapiro MJ, Berrocal AM, Murray TG, Martinez-Castellanos MA, Hubbard GB. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment. Pediatrics. 2020 Mar 31. PMID: 32234794.

View in: PubMed
Rodriguez SH, Peyton C, Lewis K, Andrews B, Greenwald MJ, Schreiber MD, Msall ME, Blair MP. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343. PMID: 31233150.

View in: PubMed
Schechet SA, Rodriguez SH, Shapiro MJ, Blair MP. Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity". Taiwan J Ophthalmol. 2019 Apr-Jun; 9(2):136-137. PMID: 31198676.

View in: PubMed
Anand N, Blair MP, Greenwald MJ, Rodriguez SH. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6. PMID: 30797978.

View in: PubMed
Theophanous C, Schechet S, Rodriguez SH, Blair M. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896. PMID: 30457649.

View in: PubMed
Blair M, Gonzalez JMG, Snyder L, Schechet S, Greenwald M, Shapiro M, Rodriguez SH. Bevacizumab or laser for aggressive posterior retinopathy of prematurity. Taiwan J Ophthalmol. 2018 Oct-Dec; 8(4):243-248. PMID: 30637196.

View in: PubMed
Blair MP, Hilkert Rodriguez S, Chan RVP, Shapiro MJ. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71. PMID: 30243341.

View in: PubMed
Tina H. Chen, Kathryn A. Colby, Sarah Hilkert Rodriguez, Mark B. Slidell, Jessica J. Kandel, Hassan A. Shah. Availability of Resources for After-Hours Surgical Management of Eye Injuries. J Acad Ophthalm. 2018; 1(10):e92-e97.

View Publication
Hilkert SM, Parness-Yossifon R, Mets-Halgrimson R, Mets MB. Response to Galvis et al.'s "Myopia rates in a genetically isolated population". Ophthalmic Genet. 2018 04; 39(2):295. PMID: 29172911.

View in: PubMed
Silas MR, Hilkert SM, Reidy JJ, Farooq AV. Posterior keratoconus. Br J Ophthalmol. 2018 07; 102(7):863-867. PMID: 29122822.

View in: PubMed
Hilkert SM, Parness-Yossifon R, Mets-Halgrimson R, Mets MB. Ocular biometry and determinants of refractive error in a founder population of European ancestry. Ophthalmic Genet. 2018 Jan-Feb; 39(1):11-16. PMID: 28569566.

View in: PubMed
Hilkert SM, Farooq AV, Greenwald MJ . Retinoblastoma: a global perspective. Curr Ophthalmol Rep. 2017; (5):119-127.
Hilkert SM, Koreishi AF, Pyatetsky D. Poststreptococcal syndrome presenting as posterior scleritis in a child. J AAPOS. 2017 Apr; 21(2):163-165. PMID: 28007653.

View in: PubMed
Hilkert SM, Cebulla CM, Jain SG, Pfeil SA, Benes SC, Robbins SL. Breaking bad news: A communication competency for ophthalmology training programs. Surv Ophthalmol. 2016 Nov - Dec; 61(6):791-798. PMID: 27134009.

View in: PubMed
DiVittorio KM, Leevy WM, O'Neil EJ, Johnson JR, Vakulenko S, Morris JD, Rosek KD, Serazin N, Hilkert S, Hurley S, Marquez M, Smith BD. Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics. Chembiochem. 2008 Jan 25; 9(2):286-93. PMID: 18076009.

View in: PubMed